University of Chicago :: Department of Pathology ::

Quick Links

Beverly Baron , MD

Associate Professor

Medical Director, Blood Bank Section

5841 S. Maryland Avenue, MC 0007
Chicago, IL 60637-1470
Telephone: (773) 702-1439
Fax: (773) 702-4543
Beverly.Baron@uchospitals.edu

Blood banking, especially drug-related antibody formation and use of red cell exchange in sickle cell disease.

Biological function of the gene BCL6; translocations or mutations in this gene accompany lymphomas, especially large-cell B-cell lymphomas.

Bansal, I., Calhoun, B.E., Joseph, C.P., Pothiawala, M., and Baron, B.W. A comparative study of reducing the extracellular potassium concentration in packed red blood cells by washing and by reduction of additive solution. Transfusion (in press).
Baron, J.M. and Baron, B.W. Thrombotic thrombocytopenic purpura and its look-alikes. Clin. Adv. in Hematol. & Oncol. 3(11):868-874, 2005.
Baron, B.W., Langan, G., Huo, D., Baron, J. M., and Montag, A. Squamous cell carcinomas of the skin at ear tag sites in aged FVB/N mice. Comparative Medicine 55(3):231-235, 2005.
Baron, B.W., Anastasi, J., Montag, A., Huo, D., Baron, R.M., Karrison, T., Thirman, M.J., Subudhi, S., Chin, R.K., Felsher, D.W., Fu, Y.-X., McKeithan, T.W., and Baron, J.M. The human BCL6 transgene promotes the development of lymphomas in the mouse. Proc. Natl. Acad. Sci. USA 101(39):14198-14203, 2004.

Baron, B.W., van Besien, K., Hoffman, P.C., Kohn, O.F., Rossof, A.H., and Baron, J.M. Thrombotic thrombocytopenic purpura following cephalosporin administration--a possible relationship. Transfusion 43(9):1371-1321, 2003.
Baron, B.W., Jeon, H.-R., Glunz, C., Peterson, A., Cohen, R., Hanauer, S., Rubin, D., Hart, J., and Baron, J. First two patients with ulcerative colitis who developed classical thrombotic thrombocytopenic purpura successfully treated with medical therapy and plasma exchange. J. Clin. Apheresis 17(4): 204-206, 2002.
Herschel, M., Karrison, T., Wen, M., Caldarelli, L., and Baron, B. Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates. Pediatrics 110 (No. 1), 127-130, July 2002. (Article selected for abstract in Year Book of Neonatal and Perinatal Medicine, Mosby-Year Book, Inc., 2003).
Baron, B. W., Anastasi, J., Thirman, M. J., Furukawa, Y., Fears, S., Kim, D. C., Simone, F., Birkenbach, M., Montag, A., Sadhu, A., Zeleznik-Le, N., and McKeithan, T. W. The human programmed cell death-2 gene is a target of BCL6 repression: Implications for a role of BCL6 in the downregulation of apoptosis. Proc. Natl. Acad. Sci. USA 99:2860-2865, 2002.